Given the relatively low mean cardiac radiation dose and incomplete RT course, together with the typical time window for ICI myocarditis (commonly 17–65 days after the first PD-1 dose and independent of cumulative drug dose), the multidisciplinary team considered immunotherapy-related myocardial injury to be the most likely cause of the acute cardiac deterioration. Here, PDCD1 is linked to myocarditis.